CDK-TCIP2

• Target :

  Bcl-6|||CDK

• Related Pathways :

  Immunology/Inflammation|||Cell Cycle/Checkpoint

• Bioactivity :

  DK-TCIP2 is an anticancer agent formed by linking the CDK9 inhibitor SNS-032 and the BCL6 inhibitor BI-3812. This compound exhibits anticancer activity both in vivo and in vitro, making it suitable for research in lymphoma.

• Smiles :

  C(F)(F)(F)C1=C2C(CN(C[C@H]3C[C@@H](C(F)(F)F)CCC3)C2=O)=NC(N)=N1

• Molecular Formula :

  C52H67ClN12O8S2

• Molecular Weight :

  1087.75

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C